Change over period: —
NSE · MEDICO
MEDICO
-66.4% from the 52-week high · +1.4% above the low
Medico Remedies Ltd. engages in the manufacture, supply, and exportation of pharmaceutical drugs. The company is headquartered in Thane, Maharashtra. The company went IPO on 2018-02-08. The company is engaged in the manufacturing of medicines including Diuretics, Antimalarials, NSAIDS Tablets, Antireterovirals, Anti-Ulcer Drugs and Antacids Tablets. The company has manufacturing and marketing capabilities in formulation with focus on anti-infective, Beta-Lactums, cephalosporins, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins, haematinics and other supplements. In addition, the Company also manufactures other drugs, such as non-steroidal anti-inflammatory drugs (NSAIDS), antihistaminic, anti-diabetics, cardiovascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and cream, and gel for various therapeutic segments. Its products include Doxycycline Capsules, Zenof-400 (Ofloxacin Tablets 400mg), Azithromycin Tablets, Aciclovir Tablets, Cipta Tablets, Cotrimoxazole Tablets, Tos Syrup, Paediatric Co-Trimozole Oral, Med Reactin (Cyproheptadine), and Medivit Syrup.
The short version. Promoter holding was 61.38% in Sep 2026, down 5.45 points over 8 quarters.
1 · The price
How has the stock traded?
MEDICO trades 66.4% below its 52-week high and 1.4% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Down 5.45 pts over 8 quarters.
Up 0.21 pts over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 66.83 | 63.79 | 62.59 | 61.38 | 61.38 | 61.38 | 61.38 | 61.38 | -5.45 |
| FII | 0.39 | 0.12 | 0.07 | 0.3 | 0.49 | 0.03 | 0.08 | 0.6 | +0.21 |
| DII | 0.78 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | -0.78 |
| Public | 32.0 | 36.08 | 37.33 | 38.3 | 38.13 | 38.59 | 38.54 | 38.02 | +6.02 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for MEDICO are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about MEDICO
What is the MEDICO share price?
MEDICO (MEDICO) last closed at ₹18.83, up 3.23% on the day. Its 52-week range is ₹17.99 to ₹54.24.
What is the market cap of MEDICO?
MEDICO has a market capitalisation of about ₹151 crore. Its price-to-earnings ratio is 11.0.
How are MEDICO's latest results?
Promoter holding was 61.38% in Sep 2026, down 5.45 points over 8 quarters.
Who owns MEDICO?
As of Sep 2026, shareholding was: Promoter 61.38%, FII 0.6%, Public 38.02%.
How many mutual funds hold MEDICO?
0 mutual fund schemes held MEDICO in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 16 Mar 2023 · Stock Split From Rs.10/- to Rs.2/-
- 16 Nov 2021 · Bonus issue 3:1
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.